Effect of coinfection with STDs and of STD treatment on HIV shedding in genital-tract secretions: Systematic review and data synthesis

Sexually Transmitted Diseases

Volumn 27, Issue 5, 2000, Pages 243-248

  Rotchford, Karen ^a   Strum, A Willem ^b   Wilkinson, David ^c,d  

^a SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^b UNIVERSITY OF KWAZULU NATAL   (South Africa)

^c UNIVERSITY OF ADELAIDE   (Australia)

^d UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHLAMYDIASIS; GONORRHEA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MIXED INFECTION; PROSTATE SECRETION; REVIEW; SEXUALLY TRANSMITTED DISEASE; URETHRITIS; VAGINA SECRETION; VIRUS LOAD; VIRUS SHEDDING;

EID: 0034024895     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007435-200005000-00001     Document Type: Review

References (58)

1. Wasserheit JN. Epidemiological synergy: Interrelationships between HIV infection and other STDs. Sex Transm Dis 1992; 19:61-77.
2. Plummer FA, Simonsen NJ Cameron DW, et al. Cofactors in male-female transmission of HIV type 1. J Infect Dis 1991; 163:233-9.
3. Cameron DW, Simonsen JN, D'Costa LJ, et al. Female to male transmission of human immunodeficiency virus type 1: risk factors for seroconversion in men. Lancet 1989; 2:403-407.
4. De Vincenzi I. A longitudinal study of HIV transmission by heterosexual partners. N Engl J Med 1994; 331:341-346.
5. Hayes R, Schulz K, Plummer F. The cofactor effect of genital ulcers on the per-exposure risk of HIV transmission in sub-Saharan Africa. J Trop Med Hyg 1995; 98:1-8.
6. Center for Disease Control and Prevention. HIV prevention through early detection and treatment of other STDs - United States. MMWR 1998; 47:1-7.
7. Grosskurth H, Mosha F, Todd J, et al. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial. Lancet 1995; 346:530-536.
8. Wawer MJ, Sewankambo NK, Serwadda D, et al. Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial. Lancet 1999; 353:525-535.
9. Atkins M, Carlin E, Emery V. Fluctuations of HIV load in semen of HIV positive patients with newly acquired sexually transmitted diseases. BMJ 1996; 313:341-313.
10. Moss GB, Overbaugh J, Welch M, et al. Human immunodeficiency virus DNA in urethral secretions in men: associations with gonococcal urethritis and CD4 cell depletion. J Infect Dis 1995; 172:1469-1474.
11. Cohen MS, Hoffman IF, Royce RA, et al. Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. Lancet 1997; 349: 1868-1873.
12. John G C, Nduati RW, Mbori-Ngacha D, et al. Genital shedding of human immunodeficiency virus Type 1 DNA during pregnancy: association with immunosuppression, abnormal cervical or vaginal discharge, and severe vitamin A deficiency. J Infect Dis 1997; 175:57-62.
13. Clemetson DBA, Moss GB, Willerford DM, et al. Detection of HIV DNA in cervical and vaginal secretions. JAMA 1993; 22:2860-2864.
14. Ghys PD, Fransen K, Diallo MO, et al. The associations between cervicovaginal HIV shedding, sexually transmitted diseases and immunosuppression in female sex workers in Abidjan, Cote d'Ivoire. AIDS 1997; 11:F85-F93.
15. Kreiss J, Willerford DM, Hensel M, et al. Association between cervical inflammation and cervical shedding of human immunodeficiency virus DNA. J Infect Dis 1994; 170:1597-1601.
16. Mostad SB, Overbaugh J, DeVange DM, et al. Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina. Lancet 1997; 350:922-927.
17. Dyer JR, Eron JJ, Hoffman IF, et al. Association of CD4 cell depletion and elevated blood and seminal plasma human immunodeficiency virus type 1 (HIV-1) RNA concertrations with genital ulcer disease in HIV-1 infected men in Malawi. J Infect Dis 1998; 177:224-227.
18. Eron JJ, Gilliam B, Fiscus S, et al. HIV-1 shedding and chlamydial urethritis. JAMA 1996; 275:36.
19. Anderson DJ, O'Brien TR, Politch JA. Effects of disease stage and zidovudine therapy on the detection of human immunodeficiency virus type 1 in semen. JAMA 1992; 267:2769-2774.
20. Xu C, Politch JA, Tucker L, et al. Factors associated with increased levels of human immunodeficiency virus type 1 DNA in semen. J Infect Dis 1997; 176:941-947.
21. Henin Y, Mandelbrot L, Henrion R, et al. Virus excretion in the cervicovaginal secretions of pregnant and non pregnant HIV infected women. J Acquir Immune Defic Syndr Hum Retrovirol 1993; 6:72-75.
22. Goulston C, Mc Farland W, Katzenstein DJ. Human immunodeficiency virus type 1 RNA shedding in the female genital tract. J Infect Dis 1998; 177:1100-1103.
23. Coombs RW, Speck CE, Huges JP, et al. Association between culturable human immunodeficiency virus type 1 (HIV-1) in semen and HIV 1 RNA levels in semen and blood: evidence for compartmentalization of HIV-1 between semen and blood. J Infect Dis 1998; 177:320-30.
24. Uvin Cu S, Caliendo AM. Cervicovaginal human immunodeficiency virus secretion and plasma viral load in human immunodeficiency virus-seropositive women. Obstet Gynecol 1997; 90:739-743.
25. Gupta P, Mellors J, Kingsley L, et al. High viral load in semen of human immunodeficiency virus type-1 infected men at all stages of disease and its reduction by therapy with protease and non-nucleoside reverse transcriptase inhibitors. J Virol 1997; 71:6271-6275.
26. Rasheed S, Li Z, Xu D, et al. Presence of cell-free human immunodeficiency virus in cervicovaginal secretions is independent of viral load in the blood of human immunodeficiency virus-infected women. Am J Obstet Gynecol 1996; 175:122-129.
27. Iversen AK, Larsen R, Jensen T, et al. Distinct determinants of human immunodeficiency virus type-1 RNA and DNA loads in vaginal and cervical secretions. J Infect Dis 1998; 177:1214-1220.
28. Goulston C, Stevens E, Gallo D, et al. HIV in plasma and genital secretions during the Menstrual cycle. J Infect Dis 1996; 174:858-861.
29. Vernazza PL, Gilliam BL, Dyer J, et al. Quantification of HIV in semen: correlation with antiviral treatment and immune status. AIDS 1997 1997; 11:987-993.
30. Liuzzi G, Chirianni A, Clementi M, et al. Analysis of HIV-1 load in blood, semen and saliva: evidence for different viral compartments in a cross-sectional and longitudinal study. AIDS 1996; 10:F51-F56.
31. Ilaria G, Jacobs JL, Plosky B, et al. Detection of HIV-1 DNA sequences in pre-ejaculatory fluid. Lancet 1992; 340:1469.
32. Tindall B, Evans L, Cunningham P. Identification of HIV-1 in semen following primary infection. AIDS 1992; 6:949-952.
33. Vernazza PL, Eron JJ, Cohen MS, et al. Detection and biological characterization of infectious HIV-1 in semen of seropositive men. AIDS 1994; 8:1325-1329.
34. Hamed KA, Winters M, Holodniy M, et al. Detection of human immunodeficiency virus type 1 in semen: effect of disease stage and nucleoside therapy. J Infect Dis 1993; 167:798-802.
35. Mermin JH, Holodniy M, Katzensten DA, et al. Detection of human immunodeficiency virus DNA and RNA in semen by PCR. J Infect Dis 1991; 164:769-772.
36. Kreiger JN, Coombs RW, Collier AC, et al. Recovery of human immunodeficiency virus type-1 from semen: minimal impact of stage of infection and current antiviral chemotherapy. J Infect Dis 1991; 163:386-388.
37. Vernazza PL, Gilliam BL, Flepp M, et al. Effect of antiviral treatment on the shedding of HIV-1 in semen. AIDS 1997; 11:1249-1254.
38. Dyer JR, Gilliam BL, Eron JJ, et al. Shedding of HIV-1 in semen during primary infection. AIDS 1997; 11:543-545.
39. Uvin Cu S, Caliendo AM, Reinert SE, et al. HIV-1 in the female genital tract and the affect of antiretroviral therapy. AIDS 1998; 12:826-827.
40. Kilmarz PH, Limpakarnjanarat K, Supawitkul S, et al. Mucosal disruption due to use of a widely-distributed commercial vaginal product: potential to facilitate HIV transmission. AIDS 1998; 12:767-773.
41. Van Voorhis BJ, Martinez A, Mayer K, et al. Detection of HIV type 1 in semen from seropositive men using culture and PCR DNA amplification techniques. Fertil Steril 1991; 55:588-594.
42. Dyer JR, Kazembe P, Vernazza PL, et al. High levels of human immunodeficiency virus type 1 in blood and semen of seropositive men in sub-Saharan Africa. J Infect Dis 1998; 177:1742-1746.
43. Nielsen K, Boyer P, Dillon M, et al. Presence of HIV type 1 and HIV type 1 specific antibodies in cervicovaginal secretions of infected mothers and in the gastric aspriates of their infants. J Infect Dis 1996; 173:1001-1004.
44. Zhu T, Wang N, Carr. A et al. Genetic characterization of human immunodeficiency virus type 1 in blood and genital secretions: evidence for viral compartmentalization and selection during sexual transmission. J Virol 1996; 70:3098-3107.
45. Zorr B, Schafer APA, Dilger et al. HIV detection in endocervical swabs and mode of HIV infection. Lancet 1994; 343:852.
46. Anderson DJ, JA. P, Martinez A. White blood cells and HIV-1 in semen from vasectomized seropositive men. Lancet 1991; 338:573-574.
47. Pomerantz RJ, Dela Monte SM, Donergan SP, et al. HIV infection of the uterine cervix. Ann Intern Med 1988; 108:321-327.
48. O'Shea S, Cordery M, Barrett WY, et al. HIV excretion patterns and specific antibody responses in body fluids. J Med Virol 1990; 31: 291-296.
49. Vogt MW, Witt DJ, Craven DE, et al. Isolation patterns of HIV from cervical secretions during the menstrual cycle of women at risk for AIDS. Ann Intern Med 1987; 106:380-382.
50. Zagury D, Bernard J, Leibowitch J, et al. HTLV-III in cells cultured from semen of two patients with AIDS. Science 1984; 226:449-451.
51. Vogt MW, Craven DE Crawford DE, et al. Isolation of HTLV III/LAV from cervical secretions of women at risk of AIDS. Lancet 1986; 1:525-527.
52. Wofsy, Hauer LB, Michaelis BA, et al. Isolation of AIDS associated with retrovirus from genital secretions of women with antibodies to the virus. Lancet 1986; 1:527-529.
53. Gilliam BL, Dyer J, Fiscus SA, et al. Effects of reverse transcriptase inhibitor therapy on the HIV-1 viral burden in semen. J Acquir Immun Defic Syndr Human Retrovirol 1997; 15:54-60.
54. Dyer JR, Gilliam BL, Eron JJ, et al. Quantitation of human immunodeficiency virus type 1 RNA in cell free seminal plasma: comparison of NASBA with Ampiocor reverse transcription PCR amplification and correlation with quantitative culture. J Virol Methods 1996; 60:161-170.
55. Eron JJ, Pietro L, Vernazza D, et al. Resistance of HIV-1 to antiretroviral agents in blood and seminal plasma: implications for transmission. AIDS 1998; 12:F181-F189.
56. Chalmers I, Altman DG. Systematic Reviews. London: BMJ Publishing Group, 1995.
57. Hennekens CH, Buring JE. Epidemiology in Medicine. Boston: Little Brown, 1987.
58. Egger M, Schneider M, Smith GD. Spurious precision? Meta-analysis of observational studies. BMJ 1998; 316:40-4.